Identity
PTD-DBM is a synthetic peptide combining a protein-transduction domain (PTD) — a sequence that helps it cross cell membranes — with a Dishevelled-binding motif (DBM). It is studied as a topical hair-growth agent, which places it at the edge of the cosmetic/therapeutic border even though it is sold as a research chemical.
Mechanism (as proposed)
The target is the Wnt/β-catenin pathway, a central driver of hair-follicle regeneration. A protein called CXXC5 acts as a negative feedback brake on that pathway by binding Dishevelled. PTD-DBM is designed to block the CXXC5-Dishevelled interaction, lifting the brake and letting Wnt signalling run — which in follicle biology favours regrowth. The logic is disinhibition, much like several other compounds in this register: don't push the accelerator, remove the brake. The mechanism is coherent and the pathway is real. Two honest qualifiers: releasing a growth pathway raises theoretical proliferative concerns, and pathway activation in a model is not a demonstrated human result.
Reading the evidence honestly
The regrowth evidence is mouse-stage and concentrated in the originating (largely Korean) groups, and a great deal of it pairs PTD-DBM with valproic acid, another Wnt activator — so the effect attributable to PTD-DBM alone is harder to isolate than the headlines suggest. There are no human studies of any kind. That combination of a real target, a single-source animal signal, frequent co-treatment, and zero human data is exactly what a D grade is for: genuinely interesting, nowhere near established.